P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3‐21R110.
Autor: | Hengeveld, P., Ertem, Y. E., Dubois, J., Mellink, C., van der Kevie‐Kersemaekers, A.‐M., Evers, L., Heezen, K., Kolijn, P. M., Mook, O., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P., Niemann, C., Kater, A., Langerak, A., Levin, M.‐D. |
---|---|
Zdroj: | HemaSphere; 2022 Supplement 3, Vol. 6, p508-509, 2p |
Databáze: | Complementary Index |
Externí odkaz: |